Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
#484
Rank
$50.218 B
Marketcap
India
Country
₹1,973.70
Share price
0.00%
Change (1 day)
21.96%
Change (1 year)
Categories
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology,…
Key Metrics
Trailing P/E
38.92
Forward P/E
30.12
EPS (TTM)
$50.46
Forward EPS
$64.88
Price / Book
5.64
EV / EBITDA
26.7x
Beta
0.12
Dividend Yield
0.81%
Return on Equity
—
Return on Assets
—
Debt / Equity
5.52
Current Ratio
—
Gross Margin
78.92%
Operating Margin
23.25%
Net Profit Margin
20.19%
Free Cash Flow
—
Charts
Price history and financial performance over time.
Price & Market Cap
Jul 6 – Aug 3
+2.65%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$6.174B
Latest Net Income$1.217B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Sun Pharmaceutical Industries Limited with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
SUNPHARMA.NS
No recent news available. Set FINNHUB_API_KEY to enable news.
